Autopsy report · NCT04133766

Community-based Nutrition Program Effectiveness Evaluation in Afghanistan

“Funding for the study withdrawn by sponsor after baseline data collected”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 9 months before it stopped.
• 4,076 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Na

Sponsor

FHI 360

Sponsor type

University, hospital or other

Conditions

Child Malnutrition; Breast Feeding; Nutrition

Interventions

Community Based Nutrition Package (CNBP)

Participants

4,076

Sites

3

Countries

Afghanistan

Trials that died the same way

• Pasireotide in Hyperinsulinemic Hypoglycemia
  “Funding was withdrawn by Sponsor prior to start of study” (87% match in meaning)
• NRX-1074 in Early Course Schizophrenia
  “The study was withdrawn by the sponsor.” (84% match in meaning)
• Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial
  “Sponsor withdrew the study” (83% match in meaning)
• Safety and Efficacy of IMC-C103C as Monotherapy and in Combination With Atezolizumab
  “Study withdrawn by Sponsor” (82% match in meaning)
• A Study of Pemetrexed Maintenance With or Without ADXS11-001 Immunotherapy in Patients With Human Papillomavirus Positive (HPV+), NSCLC Following First-Line Induction Chemotherapy
  “Study was withdrawn per sponsor decision” (82% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.